MEDICALLY REVIEWED

HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)

breast cancer trodelvy sacituzumab govitecan

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

hypertension high blood pressure
Young Adults in England Unaware They Have High Blood Pressure

A considerable number of young individuals in England, approximately 170,000 aged 16 to 24, have high blood pressure without their knowledge, experts warn. The Office for National Statistics (ONS) reports that around five in 100 young men and one in 100 young women are affected. Although hypertension may not cause initial symptoms, it strains the heart and blood vessels, leading to half of the heart attacks and strokes in the UK.

Read More »